Der var enighed om i produktresuméet at anbefale individualisering af dosis for at komme ud over clearance- afvigelighed mellem patienter med nedsat leverfunktion.
Use in patients with hepatic impairment: it was agreed to recommend in the SPC the individualization of dosage to overcome clearance variability between patients with hepatic impairment.